But it has to use the brand names "Matador" or "Maverick." The current problem began in 2006, when the company put out a new package: court documents call it the world's first no-name brand of cigarette
As the FDA considers the pending applications, it is imperative the agency carefully reviews manufacturer marketing plans, advertising, and perception studies to confirm the products do not appeal to youth or new users
Why leave off eight additional e-cigarettes and devices from the agencys impressive list when the IQOS authorizations would add them
Among them, there are both intrinsic and environmental/acquired contributors, such as sex, age, somatotype/weight, sport habits, traumas, surgery, diet, and pain cognitions [19]
Conclusion Vaping presents a complex interplay of risks, especially when it comes to cardiovascular health and blood pressure
There are data from a range of other studies to indicate that appeal is lower with standardized packaging and this may help to explain the observed decline in prevalence